Nadia Pasinetti
Overview
Explore the profile of Nadia Pasinetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
533
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Colciago R, Lancellotta V, De Santis M, Bonzano E, De Rose F, La Rocca E, et al.
Crit Rev Oncol Hematol
. 2024 Oct;
204:104537.
PMID: 39454738
Male breast cancer (MaBC) is an uncommon disease. It is generally assimilated to post-menopausal female breast cancer and treated accordingly. However, the real impact of radiation therapy, after both mastectomy...
2.
Barbera F, Frassine F, Volpi G, Ghedi B, Pasinetti N
Radiol Med
. 2023 Aug;
128(12):1542-1552.
PMID: 37640897
Background: Platinum-based chemoradiotherapy and brachytherapy are the standard treatment for locally advanced cervical cancer. Reported long-term outcomes for treated with both IMRT and 3D-Image-guided-adaptive brachytherapy are lacking. Methods: This retrospective...
3.
De Rose F, Colciago R, Lucidi S, La Rocca E, Prisco A, Bonzano E, et al.
Curr Oncol
. 2023 Aug;
30(8):7489-7498.
PMID: 37623023
Background: We assessed the current practice concerning the axillary management of breast cancer (BC) patients undergoing upfront surgery among radiation oncologists (ROs) practising in Italy. Methods: An online survey via...
4.
Boerma M, Azimzadeh O, Pasinetti N, Monceau V
Front Oncol
. 2022 Dec;
12:1087928.
PMID: 36483033
No abstract available.
5.
Ciabattoni A, Gregucci F, De Rose F, Falivene S, Fozza A, Daidone A, et al.
Tumori
. 2022 Sep;
108(2_suppl):1-144.
PMID: 36112842
Introduction: Breast cancer is the most common tumor in women and represents the leading cause of cancer death. Radiation therapy plays a key-role in the treatment of all breast cancer...
6.
Aristei C, Bolukbasi Y, Kaidar-Person O, Pfeffer R, Arenas M, Boersma L, et al.
Crit Rev Oncol Hematol
. 2022 Aug;
177:103774.
PMID: 35917884
We report on the third Assisi Think Tank Meeting (ATTM) on breast cancer, a brainstorming project which involved European radiation and clinical oncologists who were dedicated to breast cancer research...
7.
Dondi F, Pasinetti N, Guerini A, Piazza C, Mattavelli D, Bossi P, et al.
Head Neck
. 2022 Jul;
44(11):2395-2406.
PMID: 35818852
Background: To retrospectively investigate the prognostic role of baseline F-FDG PET/CT in squamous cell carcinoma (SCC) of the paranasal sinuses. Methods: Clinical features and PET/CT semiquantitative parameters of 49 patients...
8.
Colosini A, Bernardi S, Foroni C, Pasinetti N, Guerini A, Russo D, et al.
Biomedicines
. 2022 Jun;
10(6).
PMID: 35740343
We propose a pilot, prospective, translational study with the aim of identifying possible molecular markers underlying metastatic prostate cancer (PC) evolution with the use of liquid biopsy. Twenty-eight castrate sensitive,...
9.
Albano D, Pasinetti N, Dondi F, Giubbini R, Tucci A, Bertagna F
J Clin Med
. 2022 Mar;
11(5).
PMID: 35268301
The goal of this retrospective study was to analyze and compare the prognostic role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (2-[F]-FDG PET/CT) features and sarcopenia, estimated by CT of PET...
10.
Dondi F, Pasinetti N, Gatta R, Albano D, Giubbini R, Bertagna F
J Clin Med
. 2022 Feb;
11(3).
PMID: 35160067
The aim of this study was to compare two different tomographs for the evaluation of the role of semiquantitative PET/CT parameters and radiomics features (RF) in the prediction of thyroid...